When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Becker Capital Management Inc. lessened its stake in Merck and Co., Inc. (NYSE: MRK) by 2.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchan
Bright Futures Wealth Management LLC. purchased a new position in shares of Merck and Co., Inc. (NYSE: MRK) in the undefined quarter, according to its most recent filing with the Securities and Exchan
Davis R M Inc. lessened its stake in Merck and Co., Inc. (NYSE: MRK) by 32.7% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fir
111 Capital increased its position in Merck and Co., Inc. (NYSE: MRK) by 48.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 20,391 shares of the
Diversify Wealth Management LLC lowered its position in shares of Merck and Co., Inc. (NYSE: MRK) by 63.9% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owne
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--KEY + WEL as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death Compared to KEYTRUDA Mono in Certain Patients With Earlier-Stage RCC.
RAHWAY, N.J. & NUTLEY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--WELIREG Plus LENVIMA Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated RCC Pati
American Century Companies Inc. increased its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 20.9% during the third quarter, according to the company in its most recent disclosure with the Secu
Banco Santander S.A. lessened its position in shares of Merck and Co., Inc. (NYSE: MRK) by 58.3% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fun
Artisan Partners Limited Partnership raised its position in shares of Merck and Co., Inc. (NYSE: MRK) by 2.6% in the undefined quarter, according to the company in its most recent disclosure with the
Merck will lay off about 150 employees across its facility in North Carolina that manufactures its human papillomavirus vaccine, Gardasil, according to a notice filed in the state's database this week
Merck stock ticked another box Friday after the firm said its Keytruda-containing regimen improved outcomes for ovarian cancer patients.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from the final analysis of the pivotal Phase 3 KEYNOTE-B96
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced KEYTRUDA® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) reduced the
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE